- NEWS AND VIEWS
The β-selection step shapes T-cell identity
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 613, 440-442 (2023)
doi: https://doi.org/10.1038/d41586-023-00025-0
References
Duke-Cohan, J. S. et al. Nature 613, 565–574 (2023).
Starr, T. K., Jameson, S. C. & Hogquist, K. A. Annu. Rev. Immunol. 21, 139–176 (2003).
Krueger, A., Ziętara, N. & Łyszkiewicz, M. Trends Immunol. 38, 128–139 (2017).
Schmitt, T. M., Ciofani, M., Petrie, H. T. & Zúñiga-Pflücker, J. C. J. Exp. Med. 200, 469–479 (2004).
Shortman, K. & Wu, L. Annu. Rev. Immunol. 14, 29–47 (1996).
Yui, M. A., Feng, N. & Rothenberg, E. V. J. Immunol. 185, 284–293 (2010).
Hu, G. et al. Immunity 48, 227–242 (2018).
Dutta, A., Zhao, B. & Love, P. E. Trends Immunol. 42, 735–750 (2021).
Li, X. et al. Science 371, 181–185 (2021).
Das, D. K. et al. J. Biol. Chem. 291, 25292–25305 (2016).
Mallis, R. J., Arthanari, H., Lang, M. J., Reinherz, E. L. & Wagner, G. J. Biol. Chem. 293, 754–766 (2018).
Mallis, R. J. et al. Proc. Natl Acad. Sci. USA 112, 8373–8378 (2015).
Michie, A. M. & Zúñiga-Pflücker, J. C. Semin. Immunol. 14, 311–323 (2002).
Yashiro-Ohtani, Y. et al. Genes Dev. 23, 1665–1676 (2009).
Mingueneau, M. et al. Nature Immunol. 14, 619–632 (2013).
Montecino-Rodriguez, E., Casero, D., Fice, M., Le, J. & Dorshkind, K. J. Immunol. 200, 2046–2056 (2018).
Lu, M. et al. J. Immunol. 175, 5848–5856 (2005).
Belyaev, N. N., Biro, J., Athanasakis, D., Fernandez-Reyes, D. & Potocnik, A. J. Immunogenetics 64, 591–604 (2012).
Mayassi, T., Barreiro, L. B., Rossjohn, J. & Jabri, B. Nature 595, 501–510 (2021).
Competing Interests
E.V.R. is a member of the Scientific Advisory Board for Century Therapeutics, and has advised A2 Biotherapeutics and Kite Pharma.